The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions

Acta Psychiatr Scand. 2011 Aug;124(2):141-51. doi: 10.1111/j.1600-0447.2011.01726.x. Epub 2011 Jun 1.

Abstract

Objective: To investigate the regional metabolite abnormalities and changes after treatment in patients with OCD with autogenous and reactive obsessions.

Method: We assessed right anterior cingulate cortex (ACC) and amygdala-hippocampal region (Am + Hpp) N-acetyl-aspartate (NAA), choline (Cho) and creatine (Cr) concentrations and NAA/Cr and Cho/Cr ratios using single-voxel proton magnetic resonance spectroscopy in 15 patients with autogenous obsessions (OCD-A), 15 patients with reactive obsessions (OCD-R) and 15 healthy controls (HC). Measurements were repeated after 16 weeks of fluoxetine treatment.

Results: Baseline ACC NAA/Cr ratios of both OCD groups were significantly lower than HC. OCD-A group had significantly lower baseline NAA/Cr ratios in the Am + Hpp than other groups. These differences were more likely to be explained by higher Cr levels in ACC. We found no significant differences and changes for Cho levels and Cho/Cr ratios between groups and within groups. Significant increase in NAA/Cr ratios of OCD-A group found in the Am + Hpp was more likely to be explained by increased NAA levels. No significant changes were found in ACC NAA/Cr ratios.

Conclusion: While disturbed energy metabolism in ACC might reflect a common pathology in patients with OCD regardless of symptom dimension, alterations in mesiotemporal lobe are more likely for autogenous obsessions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / metabolism
  • Choline / metabolism
  • Creatine / metabolism
  • Diagnostic and Statistical Manual of Mental Disorders
  • Drug Monitoring / methods
  • Female
  • Fluoxetine / administration & dosage
  • Fluoxetine / pharmacokinetics*
  • Humans
  • Limbic System* / drug effects
  • Limbic System* / metabolism
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Obsessive Behavior / drug therapy
  • Obsessive Behavior / metabolism
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / metabolism*
  • Obsessive-Compulsive Disorder / psychology
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Treatment Outcome

Substances

  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Aspartic Acid
  • N-acetylaspartate
  • Creatine
  • Choline